Published in Haematologica on February 01, 2010
Ischemic stroke as a presenting feature of VIPoma due to MEN 1 syndrome. Indian J Endocrinol Metab (2013) 0.78
Deep vein thrombosis: current status and nanotechnology advances. Biotechnol Adv (2012) 0.77
Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature (1994) 9.06
A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med (1991) 7.62
The epidemiology of venous thromboembolism. Circulation (2003) 6.97
Venous thrombosis: a multicausal disease. Lancet (1999) 5.41
Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost (2007) 4.09
Natural history of venous thromboembolism. Circulation (2003) 3.67
Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost (2000) 3.21
Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med (2002) 3.15
Vascular occlusive episodes and venous haematocrit in primary proliferative polycythaemia. Lancet (1978) 1.52
The haematocrit and platelet target in polycythemia vera. Br J Haematol (2006) 1.25
Daily aspirin--only half the answer. N Engl J Med (2004) 1.18
Venous thrombosis in the elderly. J Thromb Haemost (2007) 1.15
The role of red cells in haemostasis: the relation between haematocrit, bleeding time and platelet adhesiveness. Br J Haematol (1961) 1.11
The classification and diagnosis of erythrocytosis. Int J Lab Hematol (2008) 1.10
Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment. J Clin Invest (1991) 1.08
Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment. Blood (1991) 1.05
The effect of red blood cells on thrombin generation. Br J Haematol (2006) 1.00
Hematocrit and risk of venous thromboembolism in a general population. The Tromso study. Haematologica (2009) 0.96
Biological risk factors for deep vein trombosis. Clin Hemorheol Microcirc (2002) 0.90
Changes of hematocrit and hemoglobin concentration in the cold Himalayan environment in dependence on total body fluid. Sleep Breath (2009) 0.88
Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA (2005) 3.04
Gene variants associated with deep vein thrombosis. JAMA (2008) 2.74
Activation of inflammation and coagulation after infusion of C-reactive protein in humans. Circ Res (2005) 2.46
Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients. Arch Intern Med (2009) 2.16
Contrast-induced acute kidney injury and clinical outcomes after intra-arterial and intravenous contrast administration: risk comparison adjusted for patient characteristics by design. Am Heart J (2013) 2.09
Impact of incident venous thromboembolism on risk of arterial thrombotic diseases. Circulation (2013) 2.04
Epidemiology of cancer-associated venous thrombosis. Blood (2013) 2.00
Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study. JAMA Intern Med (2013) 1.91
Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia. Crit Care Med (2006) 1.82
New fundamentals in hemostasis. Physiol Rev (2013) 1.70
Multiple SNP testing improves risk prediction of first venous thrombosis. Blood (2012) 1.70
Thrombospondin-2 polymorphism is associated with a reduced risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol (2002) 1.62
The relationship between tissue factor and cancer progression: insights from bench and bedside. Blood (2011) 1.61
Role of the factor V Leiden mutation in septic peritonitis assessed in factor V Leiden transgenic mice. Crit Care Med (2006) 1.60
Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts. Circulation (2012) 1.59
Low molecular weight heparin attenuates multiple organ failure in a murine model of disseminated intravascular coagulation. Crit Care Med (2005) 1.58
Gene expression profiling identifies C/EBPdelta as a candidate regulator of endotoxin-induced disseminated intravascular coagulation. Am J Respir Crit Care Med (2007) 1.54
The effect of flight-related behaviour on the risk of venous thrombosis after air travel. Br J Haematol (2008) 1.50
The risk of venous thrombosis in individuals with a history of superficial vein thrombosis and acquired venous thrombotic risk factors. Blood (2013) 1.47
[Suspicion of pulmonary embolism: added value of CT depends on patient characteristics and referring individual]. Ned Tijdschr Geneeskd (2012) 1.45
Postoperative ileus is maintained by intestinal immune infiltrates that activate inhibitory neural pathways in mice. Gastroenterology (2003) 1.43
Factor V Leiden, prothrombin G20210A, and risk of sudden coronary death in apparently healthy persons. Am J Cardiol (2002) 1.41
Fluid loss does not explain coagulation activation during air travel. Thromb Haemost (2008) 1.38
A case of thrombosis at high altitude. Thromb Haemost (2005) 1.38
IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol (2004) 1.35
Multisystem morbidity and mortality in Cushing's syndrome: a cohort study. J Clin Endocrinol Metab (2013) 1.32
Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events. Circulation (2003) 1.22
Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis. Br J Haematol (2002) 1.22
Analysis of the storage and secretion of von Willebrand factor in blood outgrowth endothelial cells derived from patients with von Willebrand disease. Blood (2013) 1.18
Risk factors for venous thrombosis - current understanding from an epidemiological point of view. Br J Haematol (2010) 1.16
Arterial cardiovascular risk factors and venous thrombosis: results from a population-based, prospective study (the HUNT 2). Haematologica (2009) 1.15
Factor Xa stimulates proinflammatory and profibrotic responses in fibroblasts via protease-activated receptor-2 activation. Am J Pathol (2008) 1.13
Quantification of bias in direct effects estimates due to different types of measurement error in the mediator. Epidemiology (2012) 1.11
Additional value of procalcitonin for diagnosis of infection in patients with fever at the emergency department. Crit Care Med (2010) 1.11
A comparative study of the protein C pathway in septic and nonseptic patients with organ failure. Am J Respir Crit Care Med (2007) 1.09
Differential gene expression changes in children with severe dengue virus infections. PLoS Negl Trop Dis (2008) 1.06
Mast cell degranulation during abdominal surgery initiates postoperative ileus in mice. Gastroenterology (2004) 1.06
Confounding by Indication: Letter to the Editor. Am J Sports Med (2016) 1.05
Treatment with an anti-CD14 monoclonal antibody delays and inhibits lipopolysaccharide-induced gene expression in humans in vivo. J Clin Immunol (2003) 1.05
Protease-activated receptor-4 inhibition protects from multiorgan failure in a murine model of systemic inflammation. Blood (2007) 1.05
Experimental melanoma metastasis in lungs of mice with congenital coagulation disorders. J Cell Mol Med (2008) 1.03
Long-term survival in a large cohort of patients with venous thrombosis: incidence and predictors. PLoS Med (2012) 1.03
Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based. Blood (2008) 1.01
Inflammatory cytokines as risk factors for a first venous thrombosis: a prospective population-based study. PLoS Med (2006) 1.01
Relationship between venous and arterial thrombosis: a review of the literature from a causal perspective. Semin Thromb Hemost (2011) 1.00
Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent manner. Proc Natl Acad Sci U S A (2013) 1.00
Blood cell-derived tissue factor influences host response during murine endotoxemia. Blood Cells Mol Dis (2004) 0.99
Broadening the factor V Leiden paradox: pulmonary embolism and deep-vein thrombosis as 2 sides of the spectrum. Blood (2012) 0.99
Polymorphisms in the protein C gene as risk factor for venous thrombosis. Thromb Haemost (2009) 0.98
Intramyocardial injection of autologous bone marrow-derived ex vivo expanded mesenchymal stem cells in acute myocardial infarction patients is feasible and safe up to 5 years of follow-up. J Cardiovasc Transl Res (2013) 0.97
Prophylactic implantable cardioverter-defibrillator treatment in the elderly: therapy, adverse events, and survival gain. Europace (2011) 0.97
PTX3 predicts severe disease in febrile patients at the emergency department. J Infect (2009) 0.96
Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control study. Blood (2010) 0.96
Inhibition of the tissue factor/factor VIIa pathway does not influence the inflammatory or antibacterial response to abdominal sepsis induced by Escherichia coli in mice. J Infect Dis (2004) 0.96
High throughput mRNA profiling highlights associations between myocardial infarction and aberrant expression of inflammatory molecules in blood cells. Blood (2004) 0.94
Recurrent implantable cardioverter-defibrillator replacement is associated with an increasing risk of pocket-related complications. Pacing Clin Electrophysiol (2010) 0.94
Prospective study of homocysteine and MTHFR 677TT genotype and risk for venous thrombosis in a general population--results from the HUNT 2 study. Br J Haematol (2008) 0.93
Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients. Europace (2011) 0.93
Diversity and clinical impact of Acinetobacter baumannii colonization and infection at a military medical center. J Clin Microbiol (2010) 0.93
Hematologic variables and venous thrombosis: red cell distribution width and blood monocyte count are associated with an increased risk. Haematologica (2013) 0.92
The absolute risk of venous thrombosis after air travel: a cohort study of 8,755 employees of international organisations. PLoS Med (2007) 0.91
Cardiac device infections are associated with a significant mortality risk. Heart Rhythm (2011) 0.90
Modulation of mouse coagulation gene transcription following acute in vivo delivery of synthetic small interfering RNAs targeting HNF4α and C/EBPα. PLoS One (2012) 0.90
Intracellular storage and regulated secretion of von Willebrand factor in quantitative von Willebrand disease. J Biol Chem (2011) 0.89
Analysis of blood coagulation in mice: pre-analytical conditions and evaluation of a home-made assay for thrombin-antithrombin complexes. Thromb J (2005) 0.88
Tolerance to factor VIII in a transgenic mouse expressing human factor VIII cDNA carrying an Arg(593) to Cys substitution. Thromb Haemost (2006) 0.87
Complete abolishment of coagulant activity in monomeric disulfide-deficient tissue factor. Blood (2011) 0.87
Influence of gender on ischemic times and outcomes after ST-elevation myocardial infarction. Am J Cardiol (2012) 0.87
Haplotypes of the interleukin-1 receptor antagonist gene, interleukin-1 receptor antagonist mRNA levels and the risk of myocardial infarction. Atherosclerosis (2008) 0.86
VKORC1 and the vitamin K cycle. Vitam Horm (2008) 0.86
High factor VIIa levels do not promote tumor metastasis. Thromb Haemost (2008) 0.85
Effects of IC14, an anti-CD14 antibody, on coagulation and fibrinolysis during low-grade endotoxemia in humans. J Infect Dis (2002) 0.85
Functional thrombomodulin deficiency causes enhanced thrombus growth in a murine model of carotid artery thrombosis. Basic Res Cardiol (2003) 0.85
Sex difference in risk of second but not of first venous thrombosis: paradox explained. Circulation (2013) 0.85
Protein S levels and the risk of venous thrombosis: results from the MEGA case-control study. Blood (2013) 0.84
The spatial QRS-T angle in the Frank vectorcardiogram: accuracy of estimates derived from the 12-lead electrocardiogram. J Electrocardiol (2010) 0.84
Outcome after ST elevation myocardial infarction in patients with cancer treated with primary percutaneous coronary intervention. Am J Cardiol (2013) 0.83
Murine tissue factor coagulant activity is critically dependent on the presence of an intact allosteric disulfide. Haematologica (2012) 0.83
A randomized comparison of 1-h sodium bicarbonate hydration versus standard peri-procedural saline hydration in patients with chronic kidney disease undergoing intravenous contrast-enhanced computerized tomography. Nephrol Dial Transplant (2014) 0.83
Acute and severe coagulopathy in adult mice following silencing of hepatic antithrombin and protein C production. Blood (2013) 0.83
Gross deletions/duplications in PROS1 are relatively common in point mutation-negative hereditary protein S deficiency. Hum Genet (2009) 0.83
Role of hemostatic factors on the risk of venous thrombosis in people with impaired kidney function. Circulation (2013) 0.83
Patients with early arthritis consume less alcohol than controls, regardless of the type of arthritis. Rheumatology (Oxford) (2013) 0.82
Differential expression of tissue factor mRNA and protein expression in murine sepsis. The role of the granulocyte revisited. Thromb Haemost (2006) 0.82
Increased risk of venous thrombosis in persons with clinically diagnosed superficial vein thrombosis: results from the MEGA study. Blood (2011) 0.82
Differential effects of anticoagulants on tumor development of mouse cancer cell lines B16, K1735 and CT26 in lung. Clin Exp Metastasis (2008) 0.82
Finding the origin of pulmonary emboli with a total-body magnetic resonance direct thrombus imaging technique. Haematologica (2012) 0.82
Pulse wave velocity and flow in the carotid artery versus the aortic arch: effects of aging. J Magn Reson Imaging (2013) 0.82
Blood coagulation factors as inflammatory mediators. Blood Cells Mol Dis (2004) 0.82
Assessment of coagulation and fibrinolysis in families with unexplained thrombophilia. Thromb Haemost (2009) 0.82
PROS1 analysis in 87 pedigrees with hereditary protein S deficiency demonstrates striking genotype-phenotype associations. Hum Mutat (2008) 0.82
Transgenic mouse models of venous thrombosis: fulfilling the expectations? Semin Thromb Hemost (2007) 0.81
F9 Malmö, factor IX and deep vein thrombosis. Haematologica (2009) 0.81
Fentanyl-fluanisone-midazolam combination results in more stable hemodynamics than does urethane alpha-chloralose and 2,2,2-tribromoethanol in mice. Contemp Top Lab Anim Sci (2002) 0.81
Modified two-step model for studying the inflammatory response during myocardial ischemia and reperfusion in mice. Comp Med (2003) 0.81
The effect of homocysteine reduction by B-vitamin supplementation on inflammatory markers. Clin Chem Lab Med (2007) 0.81
Interaction between a genetic variant of the platelet fibrinogen receptor and fibrinogen levels in determining the risk of cardiovascular events. Am Heart J (2004) 0.80